文献速递主动脉疾病外周动脉疾病

急性A型主动脉夹层合并下肢灌注不良患者的结果

Outcomes of patients with acute type A aortic dissection and concomitant lower extremity malperfusion.
PubMed 文献 · J Vasc Surg · 2022-05-19

该回顾性研究分析了2002年1月至2018年6月在本三级转诊中心接受急性A型主动脉夹层修复的378例患者,其中62例(16%)合并急性下肢缺血。近端主动脉修复可解决大多数相关急性下肢缺血,孤立性急性下肢缺血不影响短期或长期生存;接受解剖外旁路术且有随访影像的患者均出现无症状移植血管闭塞。

要点

  • 378例急性A型主动脉夹层修复患者中62例(16%)合并急性下肢缺血,其中孤立性35例(9%)。
  • 任何器官灌注不良患者30天和1年死亡率均增高(比值比1.8,P=.04),总生存率降低(P<.01)。
  • 孤立性急性下肢缺血患者30天、1年死亡率及总生存率无显著差异(P=.57)。

核心结论

  • 近端修复急性A型主动脉夹层可解决大多数相关急性下肢缺血,孤立性急性下肢缺血不影响短期或长期生存。
  • 本研究中接受解剖外旁路术且有随访影像的所有患者均出现无症状移植血管闭塞,可能归因于重塑的原生动脉系统竞争性血流。
  • 作者认为快速积极恢复下肢血流是治疗急性下肢缺血灌注不良综合征的最佳方法,建议密切监测骨筋膜室综合征的发生。

研究设计与样本

  • 回顾性病历审查,在本三级转诊中心纳入2002年1月至2018年6月接受急性A型主动脉夹层修复的患者。
  • 采用单因素和多因素分析比较合并与不合并下肢灌注不良患者的结果,主要结局为30天和1年死亡率。

主要发现

  • 共378例患者接受急性A型主动脉夹层修复,平均年龄57岁,68%为男性,51%为白人。
  • 62例(16%)合并急性下肢缺血,其中35例(9%)为孤立性急性下肢缺血,27例(7%)合并至少一个其他器官灌注不良。
  • 62例急性下肢缺血患者中46例仅接受近端主动脉修复;378例中6例在24小时内死亡且未评估肢体灌注。
  • 在40例接受孤立近端修复且存活超过24小时的患者中,34例(85%)急性下肢缺血缓解。
  • 16例接受同期下肢外周血管手术的患者中,10例接受旁路手术,1例因难治性凝血病和低血压在24小时内死亡;所有6例有充分随访影像的患者均出现无症状旁路移植血管闭塞伴闭塞原生动脉再通。

关键数值与推荐

  • 任何器官灌注不良患者30天死亡率比值比1.8(P=.04),1年死亡率比值比1.8(P=.04),总生存率降低(P<.01)。
  • 孤立性急性下肢缺血患者30天死亡率、1年死亡率及总生存率无显著差异(P=.57)。

临床怎么用

  • 近端修复急性A型主动脉夹层可解决大多数相关急性下肢缺血,孤立性急性下肢缺血不影响短期或长期生存。
  • 作者认为快速积极恢复下肢血流是治疗急性下肢缺血灌注不良综合征的最佳方法。
  • 作者建议密切监测骨筋膜室综合征的发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The occurrence of acute lower limb ischemia (ALLI) is a serious risk within the context of aortic dissection repair. The aim of the present study was to examine the outcomes of patients with acute type A aortic dissection (ATAD) and concomitant lower extremity malperfusion. METHODS: We performed a retrospective medical record review at our tertiary referral center of patients who underwent ATAD repair from January 2002 to June 2018. We used univariate and multivariate analyses to compare the outcomes of patients with and without lower extremity malperfusion. The primary outcomes were 30-day and 1-year mortality. RESULTS: A total of 378 patients underwent ATAD repair during the study period. Their mean age was 57 years, 68% were men, and 51% were White. A total of 62 patients (16%) presented with concomitant ALLI, including 35 (9%) who presented with isolated ALLI and 27 (7%) who presented with ALLI and concomitant malperfusion of at least one other organ. Of the 62 patients with ALLI, 46 underwent only proximal aortic repair. Of the 378 patients, 6 died within the first 24 hours, and their limb perfusion was not assessed. Among the 40 patients who underwent isolated proximal repair and survived >24 hours, 34 (85%) had resolution of their ALLI. Of the 16 patients who underwent concomitant lower extremity peripheral vascular procedures, 10 had bypass procedures and 1 died within 24 hours due to refractory coagulopathy and hypotension. All six patients with adequate follow-up imaging studies had asymptomatic occlusion of the bypass graft with recanalization of the occluded native arteries. Patients who presented with any organ malperfusion had increased 30-day (odds ratio, 1.8; P = .04) and 1-year (odds ratio, 1.8; P = .04) mortality and decreased overall survival (P < .01). For the patients with isolated ALLI, no significant differences were found in 30-day or 1-year mortality or overall survival (P = .57). CONCLUSIONS: Proximal repair of ATAD resolves most cases of associated ALLI, and isolated ALLI does not affect short- or long-term survival. All patients with follow-up in our study who underwent extra-anatomic bypass developed asymptomatic graft occlusion, which could be attributed to competitive flow from the remodeled native arterial system. We believe that rapid and aggressive restoration of flow to the lower extremity is the best method to treat ALLI malperfusion syndrome. Close monitoring for the development of compartment syndrome is recommended.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Natour AK, Rteil A, Shepard A, et al. Outcomes of patients with acute type A aortic dissection and concomitant lower extremity malperfusion. J Vasc Surg. 2022. PMID: 35598820. doi:10.1016/j.jvs.2022.03.888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。